SmarterDividends
TAK

Takeda Pharmaceutical Company Limited

TAK

Healthcare · Stock · semiannual payer

$18.91

Fairly valued · +13% Add to Portfolio

Forward Yield

3.26%

Annual Dividend

$0.62

Payout Ratio

80%

5-Yr Growth

Ex-Date

Mar 31, 2026

Frequency

Semiannual

Summary

As of September 2026, Takeda Pharmaceutical Company Limited (TAK) yields 3.26% ($0.62 per share annually), with a blended fair-value estimate of $21.31 — +13% upside, so it screens as fairly valued. 1 years of dividend growth.

Is TAK a good dividend stock?

Mixed

Takeda Pharmaceutical Company Limited (TAK) pays a semiannual dividend yielding 3.26% ($0.62/yr), with 1 year of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Advantages

  • Never cut its dividend on record

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
3.26%
Payout Ratio
80%
Annual Dividend
$0.62
5-Yr Avg Growth
Ex-Dividend Date
Mar 31, 2026
Years of Growth
1
Frequency
semiannual
Beta
0.10
Market Cap
$60.4B
P/E Ratio
5-Yr Total Return
35%
52-Week Range
$12.99 – $19.10
Dividend Safety
Ever Cut?
No
TAK ex-dividend date & scheduleNext ex-date Mar 31, 2026 · full ex-dividend historyView →

Frequently Asked Questions